Turtlemint Fintech IPO Dips 11% on Market Debut

By Varun MittalTurtlemint Fintech IPO Dips 11% on Market Debut

Turtlemint Fintech Solutions shares list 11% below IPO price on BSE, reflecting investor concerns over financial health and valuation. See details.

🔥 Main Takeaway

Turtlemint Fintech Solutions’ stock had a rough start, listing 11% below its IPO price on the BSE, signaling market skepticism about its financial health and future profitability.

📌 What Happened?

Turtlemint Fintech shares debuted on the BSE at ₹136.20, an 11% discount from its initial public offering (IPO) price of ₹152 per share.

The stock closed its first trading day at ₹135.40, marking a 10.92% drop from the issue price and valuing the company at ₹3,987.24 crore.

This weak performance was largely expected, as the stock had already been trading at a 3.29% discount in the grey market pre-listing.

The ₹882.66-crore IPO, which ran from June 19 to June 23, was subscribed 1.20 times overall, driven mainly by qualified institutional buyers (QIBs) at 1.59 times, while retail investors subscribed 1.07 times and non-institutional investors (NII) only 0.52 times.

💰 Why It Matters

This poor listing highlights investor caution towards insurtech companies with shaky financials, even in a growing sector.

Shivani Nyati, Head of Wealth at Swastika Investmart, pointed to Turtlemint’s ongoing losses and a negative return on net worth (RoNW) of 47.29% as major red flags.

The IPO valuation of nearly 6.8 times FY25 revenue was considered expensive given the company’s lack of profitability and an 81% year-on-year revenue decline in FY24.

Future profitability hinges on the company’s ability to scale and manage Digital Partner costs, which make up 70-77% of its total expenses, making it a high-risk play.

👀 What to Watch Next

Investors should monitor Turtlemint’s next earnings reports closely for signs of improved revenue visibility and better cost management, especially concerning Digital Partner expenses.

Long-term investors with high risk tolerance might consider holding if they believe in the company’s insurtech leadership, but new investors should wait for price stability before jumping in.

The company plans to use the fresh issue proceeds to enhance tech infrastructure, develop products, and boost marketing, which could be catalysts for future growth if executed effectively.

Home/business/Article